文献速递遗传性与小管间质肾病

支链氨基酸促进常染色体显性多囊肾病囊肿发展

Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease.
PubMed 文献 · Kidney Int · 2017-03-22

在Pkd1条件敲除多囊肾小鼠模型中,从4周龄至22周龄饮水给予支链氨基酸(BCAA),BCAA组肾脏/体重比和肾、肝囊肿指数均显著高于安慰剂组,囊肿衬里细胞增殖增加且mTOR与MAPK/ERK通路上调;体外实验中亮氨酸刺激Pkd1缺失肾上皮细胞增殖并激活上述通路。作者据此认为BCAA可能对ADPKD患者有害。

要点

  • BCAA组小鼠肾脏/体重比及肾、肝囊肿指数均显著高于安慰剂组。
  • BCAA组囊肿衬里细胞增殖增加,mTOR和MAPK/ERK通路上调。
  • 体外亮氨酸刺激Pkd1缺失肾上皮细胞增殖并激活mTOR和MAPK/ERK通路。

核心结论

  • BCAA通过mTOR和MAPK/ERK通路加速ADPKD疾病进展,作者认为BCAA可能对ADPKD患者有害。

研究设计与样本

  • 对2周龄经聚肌胞苷酸诱导条件性敲除Pkd1的Pkd1flox/flox:Mx1-Cre(多囊)小鼠,从4周龄至22周龄经饮水给予BCAA。
  • 体外培养Pkd1缺失小鼠肾上皮细胞系,给予或不给予亮氨酸处理。

主要发现

  • BCAA组肾脏/体重比和肾、肝囊肿指数均显著高于安慰剂组。
  • L型氨基酸转运体1在囊肿衬里细胞中强表达。
  • BCAA组囊肿衬里细胞增殖增加,mTOR和MAPK/ERK通路上调。
  • 体外亮氨酸刺激Pkd1缺失肾上皮细胞增殖,并激活mTOR和MAPK/ERK通路。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the progressive development of kidney and liver cysts. The mammalian target of rapamycin (mTOR) cascade is one of the important pathways regulating cyst growth in ADPKD. Branched-chain amino acids (BCAAs), including leucine, play a crucial role to activate mTOR pathway. Therefore, we administered BCAA dissolved in the drinking water to Pkd1flox/flox:Mx1-Cre (cystic) mice from four to 22 weeks of age after polyinosinic-polycytidylic acid-induced conditional Pkd1 knockout at two weeks of age. The BCAA group showed significantly greater kidney/body weight ratio and higher cystic index in both the kidney and liver compared to the placebo-treated mice. We found that the L-type amino acid transporter 1 that facilitates BCAA entry into cells is strongly expressed in cells lining the cysts. We also found increased cyst-lining cell proliferation and upregulation of mTOR and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathways in the BCAA group. In vitro, we cultured renal epithelial cell lines from Pkd1 null mice with or without leucine. Leucine was found to stimulate cell proliferation, as well as activate mTOR and MAPK/ERK pathways in these cells. Thus, BCAA accelerated disease progression by mTOR and MAPK/ERK pathways. Hence, BCAA may be harmful to patients with ADPKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Yamamoto J, Nishio S, Hattanda F, et al. Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease. Kidney Int. 2017. PMID: 28341273. doi:10.1016/j.kint.2017.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。